|
1.
|
Huang X, Wong MK, Yi H, et al: Combined
therapy of local and metastatic 4T1 breast tumor in mice using
SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and
the immunostimulator B7.2-IgG fusion protein. Cancer Res.
62:5727–5735. 2002.PubMed/NCBI
|
|
2.
|
Duo J, Ying GG, Wang GW and Zhang L:
Quercetin inhibits human breast cancer cell proliferation and
induces apoptosis via Bcl-2 and Bax regulation. Mol Med Rep.
5:1453–1456. 2012.PubMed/NCBI
|
|
3.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
4.
|
Mallin K, Palis BE, Watroba N, et al:
Completeness of American Cancer Registry Treatment Data:
implications for quality of care research. J Am Coll Surg.
216:428–437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Slusarz A, Shenouda NS, Sakla MS, et al:
Common botanical compounds inhibit the hedgehog signaling pathway
in prostate cancer. Cancer Res. 70:3382–3390. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Cheng S, Gao N, Zhang Z, et al: Quercetin
induces tumor-selective apoptosis through downregulation of Mcl-1
and activation of Bax. Clin Cancer Res. 16:5679–5691. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Psahoulia FH, Drosopoulos KG, Doubravska
L, Andera L and Pintzas A: Quercetin enhances TRAIL-mediated
apoptosis in colon cancer cells by inducing the accumulation of
death receptors in lipid rafts. Mol Cancer Ther. 6:2591–2599. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Qin Y, He LY, Chen Y, Wang WY, Zhao XH and
Wu MY: Quercetin affects leptin and its receptor in human gastric
cancer MGC-803 cells and JAK-STAT pathway. Xi Bao Yu Fen Zi Mian Yi
Xue Za Zhi. 28:12–16. 2012.(In Chinese).
|
|
9.
|
Neibert KD and Maysinger D: Mechanisms of
cellular adaptation to quantum dots - the role of glutathione and
transcription factor EB. Nanotoxicology. 6:249–262. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Chen SS, Corteling R, Stevanato L and
Sinden J: Polyphenols inhibit indoleamine 3,5-dioxygenase-1
enzymatic activity - a role of immunomodulation in chemoprevention.
Discov Med. 14:327–333. 2012.PubMed/NCBI
|
|
11.
|
Heinritz W, Paasch U, Sticherling M, et
al: Evidence for a founder effect of the germline fumarate
hydratase gene mutation R58P causing hereditary leiomyomatosis and
renal cell cancer (HLRCC). Ann Hum Genet. 72(Pt 1): 35–40.
2008.PubMed/NCBI
|
|
12.
|
Comalada M, Camuesco D, Sierra S, et al:
In vivo quercitrin anti-inflammatory effect involves release of
quercetin, which inhibits inflammation through down-regulation of
the NF-kappaB pathway. Eur J Immunol. 35:584–592. 2005. View Article : Google Scholar
|
|
13.
|
Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh
TH and Huynh H: The role of activated MEK-ERK pathway in
quercetin-induced growth inhibition and apoptosis in A549 lung
cancer cells. Carcinogenesis. 25:647–659. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kuo PC, Liu HF and Chao JI: Survivin and
p53 modulate quercetin-induced cell growth inhibition and apoptosis
in human lung carcinoma cells. J Biol Chem. 279:55875–55885. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Kim WK, Bang MH, Kim ES, et al: Quercetin
decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human
colon cancer cells. J Nutr Biochem. 16:155–162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Li F and Altieri DC: The cancer
antiapoptosis mouse survivin gene: characterization of locus and
transcriptional requirements of basal and cell cycle-dependent
expression. Cancer Res. 59:3143–3151. 1999.
|
|
17.
|
Yoshida M, Yamamoto M and Nikaido T:
Quercetin arrests human leukemic T-cells in late G1 phase of the
cell cycle. Cancer Res. 52:6676–6681. 1992.PubMed/NCBI
|
|
18.
|
Ryan BM, O’Donovan N and Duffy MJ:
Survivin: a new target for anti-cancer therapy. Cancer Treat Rev.
35:553–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
